Sensai
Reading the tape…Pulling live market data…Setting the scene…
Sensai
AI Stock Dissection
AI Stock Dissection
APOLLOHOSP
Dr. Suneeta Reddy · Chennai, India
₹8,935.00
▲+0.36%Apollo Hospitals is trading near its 52-week high with strong institutional support and analyst consensus, reflecting confidence in its healthcare leadership and growth prospects despite rich valuation.
Exchange
NSI
Currency
INR
Day range
₹8,903.50 – ₹8,970.00
52-week range
₹6,696.50 – ₹9,009.00
Sector
Healthcare
Industry
Medical Care Facilities
AI investment rating
AI analysis75% confidence
Current valuation appears stretched with a P/E of 66x, though justified by strong revenue growth of 18% and healthcare sector tailwinds; trading near 52-week high suggests limited upside near-term.
0.8% below the 1-year high · trend down
Hedge-fund memo
Today
Stock is marginally up near its 52-week high, indicating continued bullish momentum
This week
Consolidating near highs as investors weigh rich valuation against growth prospects
This month
Outperforming broader market with strong institutional accumulation
Bull thesis
Bear thesis
Hidden risks
News & sentiment
Neutral
2 headlines · 2 outlets · 7d
Tone · daily average
Smart money
Named holders aren't published for this listing (common for Indian stocks). The split at left is live.
Financial health
Profitability
Growth
Balance sheet
Financial statements
Earnings intelligence
Beat estimates in 3 of 4 recent quarters (EPS actual vs. consensus).
36.76 vs 33.02254
11.32% surprise
35.9511 vs 33.18438
8.34% surprise
33.19 vs 34.18736
-2.92% surprise
Competitive landscape
| Company | Market cap | P/E | ROE | Op. margin | Rev. growth |
|---|---|---|---|---|---|
| APOLLOHOSP | 1.28T | 66.02 | 21.50% | 11.91% | 18.10% |
| TORNTPHARM | 1.85T | 76.23 | 16.99% | 20.20% | 41.80% |
| DIVISLAB | 2.08T | 81.17 |
Technical intelligence
Volume
RSI (14) · 70 overbought / 30 oversold
MACD (12,26,9) · MACD vs signal
Candlesticks, volume, RSI and MACD from 500sessions of real Yahoo daily data. Moving averages use full history, so they're accurate at the left edge. Support / resistance are the 52-week low / high. Educational — technical signals are not buy or sell calls.
Risk intelligence
Regulatory changes affecting healthcare pricing and reimbursement
Mitigation: Diversified revenue streams reduce dependency on any single regulatory environment
High debt levels limiting financial flexibility
Mitigation: Strong cash flow generation from operations supports debt servicing
Business intelligence
Competitive moat
Extensive hospital network across India, strong brand recognition, and integrated healthcare ecosystem create a competitive advantage difficult for rivals to replicate.
Supply chain
Upstream (inputs / suppliers)
↓
Downstream (customers / markets)
M&A / strategic moves
Catalyst calendar
Expansion of hospital network in underserved markets
Growth in telemedicine and digital health services
Thesis builder
Bull case
Strong healthcare sector growth, expansion of hospital network, and increasing healthcare penetration drive sustained revenue growth
Base case
Maintain market leadership position in Indian healthcare with steady 15-18% revenue growth
Bear case
High valuation and debt levels could pressure returns if growth moderates
Time horizon
3-5 years
Est. CAGR
15-18%
Entry (qual.)
Consider on dips below 8,500 INR for better risk-reward
Exit (qual.)
Re-evaluate if P/E exceeds 75x or growth falls below 10%
Overall conviction 75%
Knowledge graph
Executives & sector are live; peers are clickable → their dissection. Institutional holders shown where the exchange publishes them.
Portfolio impact
Enter tickers + weights, then see how APOLLOHOSP fits.
Scenario simulator
Simulate a macro shock and see the illustrative impact:
Tailwind for tech & enablers.
Illustrative impact
Medium prob.Directional illustration only — not modelled on this company's actuals. A real simulator needs company financials.
Explain like…
Re-explain APOLLOHOSP for a different audience:
Pick a persona to get a tailored explanation.
Sensai publishes educational market commentary, not investment advice. We are not SEBI-registered investment advisers or research analysts, and nothing here is a recommendation to buy, sell, or hold any security.
Live prices, index levels, and other market data are pulled from third-party feeds, may be delayed, and can be inaccurate or unavailable. Do not rely on them for trading decisions.
Investing in equities carries risk, including the loss of principal. Always do your own research and consider consulting a SEBI-registered adviser before making any investment decision.
Hidden opportunities
Watch next
Hold for long-term investors but new positions may be better on dips given rich valuation
Equitypandit·6d ago·regular weekly outlook
Real press coverage from the last 7 days, scored by AI for tone — click any headline for the source. This is news sentiment, not social: X / Reddit / Telegram scoring needs a paid social provider. Educational only.
Annual income statement, oldest → newest. Live via Yahoo.
30.1 vs 26.1925
14.92% surprise
| 16.19% |
| 28.75% |
| 9.50% |
| ULTRACEMCO | 3.49T | 40.80 | — | 15.48% | 15.90% |
Peers via Yahoo's similarity graph, same-sector first; fundamentals live. Ask the AI copilot below for a qualitative head-to-head.
Support (day/52w low)
₹8,903.50
Resistance (day/52w high)
₹8,970.00
Volume
1,64,857
Trend
down
RSI (14)
56
MACD
bearish
MA cross
golden
50-day MA
₹8,573.28
200-day MA
₹7,724.29
vs 200-DMA
15.7%
RSI/MACD computed from 6 months of daily closes; moving averages from Yahoo. Options positioning still needs an options feed.